Gradientech Appoints New Board Chair and Members
Gradientech has appointed three new members to its board, including a new board chair, to strengthen the company ahead of its market launch.
Swedish diagnostics company Gradientech has announced changes to its board of directors, appointing a new chair and three new members. These appointments are intended to bolster the company as it prepares for the market launch of its ultra-rapid antibiotic susceptibility testing (AST) system for in vitro diagnostics.
The newly appointed board members bring international expertise and key competencies that Gradientech believes will be vital for its upcoming commercialization phase. The company has not yet disclosed the names of the new members or their specific backgrounds, but stated the aim is to strengthen the organization to support growth.
Gradientech's QuickMIC system is designed to significantly reduce the time required to determine antibiotic susceptibility, a critical factor in treating severe infections like sepsis. Faster results can lead to quicker and more appropriate treatment decisions, potentially improving patient outcomes and combating the rise of antibiotic resistance.
The company is positioning itself for the commercial rollout of its technology. The board expansion is a strategic move to navigate the complexities of entering the market and scaling operations. Further details on the new board composition are expected to be released at a later date.